Report Categories
View AllRecent Articles
View All
VZLA Vizsla EPS beats by 44 but stock slides investors eye revenue generation timeline
What Clarus CLAR bond yields suggest about risk Q4 2025 Earnings Fall Short
Grayscale Ethereum Staking ETF ETHE Top EthereumFocused Crypto ETFs Amid Institutional Adoption Surge and ETH Price Momentum
The Thursday trading session revealed several significant developments that merit close observation from market participants
Fed Faces Dilemma as Jobs Data Underscore Persistent Inflation
Coastal Erosion Threatens UK Property Values and Infrastructure Spending The Slapton Line Case
China Confirms Order for 200 Boeing Aircraft Highlighting Aviation as Key Area for USChina Cooperation
Fintech Firm Mercury Reaches 52 Billion Valuation After 200 Million Funding Round
Portugals Meo Sues State for 82 Million Over Huawei 5G Equipment Ban
India Lacks Political Leadership Grooming System Says Arlekar Youth Urged to Enter Public Life with Awareness
WLDN Q1 2026 Earnings EPS Beat of 749 Surprise Drives Slight Stock Uptick
AAP Q1 2026 Earnings EPS Crushes Estimates with 68 Surprise Stock Slides
Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged
MCHP Q1 2026 Earnings EPS Surges Past Estimates by 106 Amid Solid Operational Execution
Gladstone Investment Corporation 4875 Notes due 2028 GAINZ Q1 2026 Earnings EPS Miss While Notes Trade Flat
SHF Holdings Inc SHFS Q3 2024 Earnings Modest Profitability Amid Cannabis Financial Services Landscape
1RT Acquisition Corp ONCH Holds Steady Near Resistance RangeBound Action Continues
ABVC BioPharma Consolidates at 139 as Support and Resistance Levels Narrow
Invesco High Income Trust II VLT Holds Near Support Amid Modest Decline
Pennant Group PNTG Dips 194 as Stock Approaches Key Support Zone
NCS Multistage Holdings NCSM Slips 135 as Traders Weigh Support at 4095
External Links
Reid Hoffman and Siddhartha Mukherjee Launch AI Cancer Research Startup Manas AI with 246 Million Funding
Bluejay Diagnostics Inc BJDX Q4 2023 Earnings EPS Misses Estimates by a Wide Margin Amid Continued Operational Challenges
Erasca Inc ERAS Edges Higher Toward Resistance as Biotech Sector Watches